Related references
Note: Only part of the references are listed.Sirolimus loaded polyol modified liposomes for the treatment of Posterior Segment Eye Diseases
Reshal Suri et al.
MEDICAL HYPOTHESES (2020)
Efficacy and Safety of Intravitreal Sirolimus for Noninfectious Uveitis of the Posterior Segment Results from the Sirolimus Study Assessing Double-Masked Uveitis Treatment (SAKURA) Program
Pauline T. Merrill et al.
OPHTHALMOLOGY (2020)
Paclitaxel incorporated exosomes derived from glioblastoma cells: comparative study of two loading techniques
Soodeh Salarpour et al.
DARU-JOURNAL OF PHARMACEUTICAL SCIENCES (2019)
Defining mesenchymal stromal cell (MSC)-derived small extracellular vesicles for therapeutic applications
Kenneth W. Witwer et al.
JOURNAL OF EXTRACELLULAR VESICLES (2019)
Nanomedicine approaches for sirolimus delivery: a review of pharmaceutical properties and preclinical studies
Azadeh Haeri et al.
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY (2018)
Strategic design of extracellular vesicle drug delivery systems
James P. K. Armstrong et al.
ADVANCED DRUG DELIVERY REVIEWS (2018)
T helper 17.1 cells associate with multiple sclerosis disease activity: perspectives for early intervention
Jamie van Langelaar et al.
BRAIN (2018)
Molecular mechanisms underpinning T helper 17 cell heterogeneity and functions in rheumatoid arthritis
Jan Piet van Hamburg et al.
JOURNAL OF AUTOIMMUNITY (2018)
Ex-Th17 (Nonclassical Th1) Cells Are Functionally Distinct from Classical Th1 and Th17 Cells and Are Not Constrained by Regulatory T Cells
Sharee A. Basdeo et al.
JOURNAL OF IMMUNOLOGY (2017)
Exosomes: Therapy delivery tools and biomarkers of diseases
Lucio Barile et al.
PHARMACOLOGY & THERAPEUTICS (2017)
Effects of Mesenchymal Stem Cell-Derived Exosomes on Experimental Autoimmune Uveitis
Lingling Bai et al.
SCIENTIFIC REPORTS (2017)
A Comprehensive Review of mTOR-Inhibiting Pharmacotherapy for the Treatment of Non-Infectious Uveitis
Joshua Blair et al.
CURRENT PHARMACEUTICAL DESIGN (2017)
Intravitreal injection of rapamycin-loaded polymeric micelles for inhibition of ocular inflammation in rat model
Wei Wu et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2016)
Exploitation of Exosomes as Nanocarriers for Gene-, Chemo-, and Immune-Therapy of Cancer
Akhil Srivastava et al.
JOURNAL OF BIOMEDICAL NANOTECHNOLOGY (2016)
Development of exosome-encapsulated paclitaxel to overcome MDR in cancer cells
Myung Soo Kim et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2016)
Intravitreal Sirolimus for Noninfectious Uveitis: A Phase III Sirolimus Study Assessing Double-masKed Uveitis TReAtment (SAKURA)
Quan Dong Nguyen et al.
OPHTHALMOLOGY (2016)
Risk of Ocular Complications in Patients with Noninfectious Intermediate Uveitis, Posterior Uveitis, or Panuveitis
Andrew D. Dick et al.
OPHTHALMOLOGY (2016)
Exosome Delivered Anticancer Drugs Across the Blood-Brain Barrier for Brain Cancer Therapy in Danio Rerio
Tianzhi Yang et al.
PHARMACEUTICAL RESEARCH (2015)
Th17 cells give rise to Th1 cells that are required for the pathogenesis of colitis
Stacey N. Harbour et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
One-Year Outcomes of the SAVE Study: Sirolimus as a Therapeutic Approach for UVEitis
Mohamed A. Ibrahim et al.
TRANSLATIONAL VISION SCIENCE & TECHNOLOGY (2015)
A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy
Yanhua Tian et al.
BIOMATERIALS (2014)
Paclitaxel is incorporated by mesenchymal stromal cells and released in exosomes that inhibit in vitro tumor growth: A new approach for drug delivery
Luisa Pascucci et al.
JOURNAL OF CONTROLLED RELEASE (2014)
Periocular Corticosteroid Injections in Uveitis Effects and Complications
H. Nida Sen et al.
OPHTHALMOLOGY (2014)
Complications of Intravitreal Injections in Patients with Diabetes
Hasanain Shikari et al.
SEMINARS IN OPHTHALMOLOGY (2014)
Bioinspired Exosome-Mimetic Nanovesicles for Targeted Delivery of Chemotherapeutics to Malignant Tumors
Su Chul Jang et al.
ACS NANO (2013)
Mesenchymal stem cell: An efficient mass producer of exosomes for drug delivery
Ronne Wee Yeh Yeo et al.
ADVANCED DRUG DELIVERY REVIEWS (2013)
Exosomes from Retinal Astrocytes Contain Antiangiogenic Components That Inhibit Laser-induced Choroidal Neovascularization
Amir Reza Hajrasouliha et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Ocular tolerability and efficacy of intravitreal and subconjunctival injections of sirolimus in patients with non-infectious uveitis: primary 6-month results of the SAVE Study
Quan Dong Nguyen et al.
JOURNAL OF OPHTHALMIC INFLAMMATION AND INFECTION (2013)
Regulation of Immune Responses by mTOR
Jonathan D. Powell et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 30 (2012)
Clinical and Histopathologic Characteristics of Rash in Cancer Patients Treated With Mammalian Target of Rapamycin Inhibitors
Yevgeniy Balagula et al.
CANCER (2012)
The role of biologic agents in the management of non-infectious uveitis
Jangwon Heo et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2012)
Tolerability and Pharmacokinetics of Intravitreal Sirolimus
Sri Mudumba et al.
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2012)
Mammalian Target of Rapamycin (mTOR) Inhibitors Potential Uses and a Review of Haematological Adverse Effects
Sofia Sofroniadou et al.
DRUG SAFETY (2011)
Correlation of optical coherence tomography with clinical and histopathological findings in experimental autoimmune uveoretinitis
Ivana Gadjanski et al.
EXPERIMENTAL EYE RESEARCH (2011)
Treatment of Brain Inflammatory Diseases by Delivering Exosome Encapsulated Anti-inflammatory Drugs From the Nasal Region to the Brain
Xiaoying Zhuang et al.
MOLECULAR THERAPY (2011)
Treatment-Associated Adverse Event Management in the Advanced Renal Cell Carcinoma Patient Treated with Targeted Therapies
Alain Ravaud
ONCOLOGIST (2011)
Common toxicities of mammalian target of rapamycin inhibitors
Scott A. Soefje et al.
TARGETED ONCOLOGY (2011)
A retrospective review of oral low-dose sirolimus (rapamycin) for the treatment of active uveitis
Brandon N. Phillips et al.
JOURNAL OF OPHTHALMIC INFLAMMATION AND INFECTION (2011)
A Novel Nanoparticle Drug Delivery System: The Anti-inflammatory Activity of Curcumin Is Enhanced When Encapsulated in Exosomes
Dongmei Sun et al.
MOLECULAR THERAPY (2010)
Ocular toxicity and distribution of subconjunctival and intravitreal rapamycin in horses
L. C. Douglas et al.
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS (2008)
Sirolimus-induced pneumonitis following liver transplantation
Rebecca J. Roberts et al.
LIVER TRANSPLANTATION (2007)
Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement
M. Dominici et al.
CYTOTHERAPY (2006)
From beach to bedside: History of the development of sirolimus
KL Napoli et al.
THERAPEUTIC DRUG MONITORING (2001)
Share Paper
